Eledon Pharmaceuticals Inc (ELDN)

Finanzdaten der Eledon Pharmaceuticals Inc-Aktie (ELDN)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	7.97%22.87	21.18	21.48	19.07	24.73
Research and Development	6.01%18.23	17.20	17.49	14.97	20.28
Operating Income/Loss	7.97%-22.87	-21.18	-	-19.07	-24.73
	18.95%-31.63	-39.03	-10.45	-17.46	-11.22
Attributable To Parent	18.95%-31.63	-39.03	-10.45	-17.46	-11.22
Available To Common Stockholders, Basic	18.12%-30.24	-36.94	-9.84	-16.13	-11.22
Basic Average Shares	1.07%113.63	112.42	-	77.16	77.16
Diluted Average Shares	1.07%113.63	112.42	-	77.16	77.16
Basic Earnings Per Share	18.18%-0.27	-0.33	-	-0.21	-0.13
Diluted Earnings Per Share	18.18%-0.27	-0.33	-	-0.21	-0.13